Hepatitis C virus (HCV) is a positive-stranded RNA virus that causes severe liver diseases, such as cirrhosis and hepatocellular carcinoma. HCV uses an RNA-dependent RNA polymerase to replicate its genome and an internal ribosomal entry site to translate its proteins. HCV infection is characterized
CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes
β Scribed by Li Ye; Xu Wang; Shihong Wang; Yanjian Wang; Li Song; Wei Hou; Lin Zhou; He Li; Wenzhe Ho
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 766 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
CD56 Ψ T cells are abundant in liver and play an important role in defense against viral infections. However, the role of CD56 Ψ T cells in control of hepatitis C virus (HCV) infection remains to be determined. We investigated the noncytolytic anti-HCV activity of primary CD56 Ψ T cells in human hepatocytes. When HCV Japanese fulminant hepatitis-1 (JFH-1)-infected hepatocytes were co-cultured with CD56 Ψ T cells or incubated in media conditioned with CD56 Ψ T cell culture supernatants (SN), HCV infectivity and replication were significantly inhibited. The antibodies to interferon (IFN)-β₯ or IFN-β₯ receptor could largely block CD56 Ψ T cell-mediated anti-HCV activity. Investigation of mechanism(s) responsible for CD56 Ψ T cell-mediated noncytolytic anti-HCV activity showed that CD56 Ψ T SN activated the multiple elements of janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway and enhanced the expression of IFN regulatory factors (IRFs) 1, 3, 7, 8, and 9, resulting in the induction of endogenous IFN-β£/β€ expression in hepatocytes. Moreover, CD56 Ψ T SN treatment inhibited the expression of HCV-supportive micro RNA (miRNA)-122 and enhanced the levels of anti-HCV miRNA-196a in human hepatocytes. Conclusion: These findings provide direct in vitro evidence at cellular and molecular levels that CD56 Ψ T cells may have an essential role in innate immune cellmediated defense against HCV infection. (HEPATOLOGY 2009;49:753-762.)
C D56 Ο© T cells are a subset of human T lymphocytes that express the cell-surface molecular, CD56, which is typically expressed by natural killer cells. 1,2 CD56 Ο© T cells express both natural killer and T cells markers; therefore, they functionally display properties of both natural killer cells and T cells. Unlike classical T cells, CD56 Ο© T cells possess the ability to rap-
π SIMILAR VOLUMES
MicroRNAs (miRNAs) are approximately 22-nucleotide noncoding RNAs that constitute silencers of target gene expression. Aberrant expression of miRNA has been linked to a variety of cancers, including hepatocellular carcinoma (HCC). Hepatitis C virus (HCV) infection is considered a major cause of chro
Cell entry of hepatitis C virus, pseudoparticles (HCVpp) and cell culture grown virus (HCVcc), requires the interaction of viral glycoproteins with CD81 and other as yet unknown cellular factors. One of these is likely to be the scavenger receptor class B type I (SR-BI). To further understand the ro
Patients with chronic renal failure undergoing hemodialysis who are infected with hepatitis C virus (HCV) may test consistently anti-HCV negative. Because CD4(+) T-cells provide help for antibody production virus-specific effector CD4(+) T-cell responses were investigated in relation to anti-HCV pos
## Abstract Hepatitis C virus (HCV) can infect and propagate in humans and chimpanzees. Whereas the chimpanzee has been used as an animal model for infection, ethical considerations, conservation, and the prohibitively high cost preclude progress for experimental research on the biology of the viru